JP2005526016A5 - - Google Patents

Download PDF

Info

Publication number
JP2005526016A5
JP2005526016A5 JP2003561581A JP2003561581A JP2005526016A5 JP 2005526016 A5 JP2005526016 A5 JP 2005526016A5 JP 2003561581 A JP2003561581 A JP 2003561581A JP 2003561581 A JP2003561581 A JP 2003561581A JP 2005526016 A5 JP2005526016 A5 JP 2005526016A5
Authority
JP
Japan
Prior art keywords
dna
delivery device
drug delivery
stabilized
supercoiled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003561581A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005526016A (ja
Filing date
Publication date
Priority claimed from GBGB0201736.6A external-priority patent/GB0201736D0/en
Application filed filed Critical
Publication of JP2005526016A publication Critical patent/JP2005526016A/ja
Publication of JP2005526016A5 publication Critical patent/JP2005526016A5/ja
Pending legal-status Critical Current

Links

JP2003561581A 2002-01-25 2003-01-23 Dnaの投薬形態 Pending JP2005526016A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0201736.6A GB0201736D0 (en) 2002-01-25 2002-01-25 DNA dosage forms
PCT/GB2003/000282 WO2003061636A2 (en) 2002-01-25 2003-01-23 Dna dosage forms

Publications (2)

Publication Number Publication Date
JP2005526016A JP2005526016A (ja) 2005-09-02
JP2005526016A5 true JP2005526016A5 (https=) 2006-02-09

Family

ID=9929749

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003561581A Pending JP2005526016A (ja) 2002-01-25 2003-01-23 Dnaの投薬形態

Country Status (10)

Country Link
US (1) US20050080028A1 (https=)
EP (1) EP1467720B1 (https=)
JP (1) JP2005526016A (https=)
AT (1) ATE427105T1 (https=)
AU (1) AU2003202685A1 (https=)
CA (1) CA2473679A1 (https=)
DE (1) DE60326930D1 (https=)
ES (1) ES2322572T3 (https=)
GB (1) GB0201736D0 (https=)
WO (1) WO2003061636A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
US8961477B2 (en) 2003-08-25 2015-02-24 3M Innovative Properties Company Delivery of immune response modifier compounds
WO2005042702A2 (en) * 2003-10-23 2005-05-12 Alza Corporation Compositions of stabilized dna for coating microprojections
US7591806B2 (en) * 2004-05-18 2009-09-22 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
DE602005025138D1 (de) 2004-08-16 2011-01-13 Fuctional Microstructures Ltd Verfahren zur herstellung einer mikronadel oder eines mikroimplantats
US8043250B2 (en) * 2005-05-18 2011-10-25 Nanomed Devices, Inc. High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US8048017B2 (en) * 2005-05-18 2011-11-01 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
CA2614927A1 (en) * 2005-07-25 2007-02-01 Nanotechnology Victoria Pty Ltd Microarray device
CA2629193C (en) 2005-11-18 2016-03-29 3M Innovative Properties Company Coatable compositions, coatings derived therefrom and microarrays having such coatings
US10525246B2 (en) 2006-12-22 2020-01-07 Nanomed Skincare, Inc. Microdevice and method for transdermal delivery and sampling of active substances
US20080214987A1 (en) * 2006-12-22 2008-09-04 Nanomed Devices, Inc. Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances
US8512679B2 (en) 2011-03-04 2013-08-20 Elwha Llc Glassy compositions
CN103717249B (zh) 2011-06-15 2017-03-22 克洛恩泰克制药股份公司 注射针和装置
KR101314091B1 (ko) * 2011-07-26 2013-10-04 연세대학교 산학협력단 치료 부위내 경피 유전자 전달을 위한 일렉트로 마이크로니들 집적체 및 이의 제조방법
JP2013052202A (ja) * 2011-09-01 2013-03-21 Kosumedei Seiyaku Kk Dnaワクチンマイクロニードル
EP2782603A1 (en) 2011-11-25 2014-10-01 Danmarks Tekniske Universitet Formulation of solid nano-sized particles in a gel-forming system

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2017507C (en) * 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
DE69034053T2 (de) * 1989-06-26 2003-12-04 Powderject Vaccines, Inc. Transformation von tierischen somatischen zellen mittels partikeln
US5697901A (en) * 1989-12-14 1997-12-16 Elof Eriksson Gene delivery by microneedle injection
CA2160878A1 (en) * 1993-04-19 1994-10-27 Medisorb Technologies International L.P. Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression
US5804566A (en) * 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
EP0714308A4 (en) * 1993-08-26 1998-07-29 Univ California METHOD, COMPOSITIONS AND DEVICES FOR THE ADMINISTRATION OF NAKED POLYNUCLEOTIDS, WHICH ENCODE FOR BIOLOGICALLY ACTIVE PEPTIDES
ATE252373T1 (de) * 1994-08-04 2003-11-15 Elan Drug Delivery Ltd Feste verabreichungssysteme zur gesteuerten freisetzung von darin eingebauten molekülen sowie verfahren zu deren herstellung
US6290991B1 (en) * 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
JP4386965B2 (ja) * 1996-04-26 2009-12-16 メルク エンド カンパニー インコーポレーテッド Dnaワクチン製剤
US6697669B2 (en) * 1998-07-13 2004-02-24 Genetronics, Inc. Skin and muscle-targeted gene therapy by pulsed electrical field
US6713291B2 (en) * 1999-01-28 2004-03-30 Alan D. King Electrodes coated with treating agent and uses thereof
EP1163024B1 (en) * 1999-01-28 2003-12-17 Cyto Pulse Sciences, Inc. Delivery of macromolecules into cells
US6743211B1 (en) * 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US6835184B1 (en) * 1999-09-24 2004-12-28 Becton, Dickinson And Company Method and device for abrading skin
US20020002136A1 (en) * 2000-06-28 2002-01-03 Hebert Rolland F. Salts of glutathione
WO2002003961A1 (en) * 2000-07-07 2002-01-17 Corixa Corporation Microspheres and adjuvants for dna vaccine delivery
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
ATE444773T1 (de) * 2001-04-20 2009-10-15 Alza Corp Mikroprojektionsanordnung mit einem überzug, der ein vorteilhaftes mittel enthält

Similar Documents

Publication Publication Date Title
JP2005526016A5 (https=)
JP2007302683A5 (https=)
CA2319872A1 (en) Pharmaceutical composition for the treatment of hepatocellular carcinoma
CA2515293A1 (en) Eicosapentaenoic acid for use in improving prognosis in the treatment of subarachnoid hemorrhage
JP2004502756A5 (https=)
JP2019523214A5 (https=)
JP2005537234A5 (https=)
CA2519432A1 (en) Pharmaceutical compositions comprising cetp inhibitors and a water-insoluble concentration-enhancing additive for the treatment of cardiovascular disease
JP2007526238A5 (https=)
JP2013542264A5 (https=)
JP2006517944A5 (https=)
JP2005538045A5 (https=)
JP2020502116A5 (https=)
JP2009517411A5 (https=)
WO2005112896A3 (en) Dosage form for delivery of multiple drug forms
WO2002000239A1 (en) Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same
JP2005519905A5 (https=)
JP2022501341A5 (https=)
ATE326949T1 (de) Verfahren zur herstellung fester dispersionen
IS8430A (is) Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
ATE374172T1 (de) Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
WO2001028589A3 (de) Formkörper mit amphiphilen äusseren phase und lipophilen inneren phase
WO2002034240A3 (en) Delayed and sustained release formulations and method of use thereof
WO2007027314A3 (en) Anti-inflammatory compositions and methods of use
JP2005511708A5 (https=)